© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#acute lymphoblastic leukemia
Children with Acute Lymphoblastic Leukemia Can Skip Brain Radiation
Childhood Leukemia Treatment Also Effective for Adolescents, Young Adults
illustration magnifier drop blood
Blood Cancer 101

Adolescent and Young Adult Leukemia Survivors Face Higher Mortality Rates

Age, sex and decade of diagnoses influenced long-term survival of adolescent and young adult leukemia survivors.
Istock/FatCamera

Some Latino Children With Acute Lymphoblastic Leukemia Face Higher Risk of Relapse

Minimal residual disease status may not be as strong a predictor of relapse in Latino children.
Red and white blood cells

COVID-19 Takes a Toll on People with Blood Cancers and Disorders

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

Research Uncovers Gaps and Opportunities in Acute Leukemia Care Across the Lifespan

Studies point to strategies to reduce disparities, improve outcomes and support shared decision-making.

FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia

Half of patients treated with the customized T cells achieved complete remission.

Seeing a Promising Future For Progress Against Childhood Cancer

For Childhood Cancer Awareness Month, the National Cancer Institute’s Director Dr. Ned Sharpless reflects on childhood cancer progress.
Generic image

Leukemia Medications

Here’s a list of approved drugs to treat leukemia including acute lymphocytic or lymphoblastic leukemia (ALL), chronic lymphocytic le...

New Approach Uncovers Epigenetic Drivers of Pediatric Leukemia

A probability approach uncovers gene expression changes in acute lymphoblastic leukemia, the most common form of cancer in children.

Iclusig

Beating Pediatric Leukemia

After being diagnosed with acute lymphoblastic leukemia, 7 year-old Ryan was officially declared in remission in April 2019.

New Resource for Understanding Childhood Leukemia

New NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia offers a comprehensive look at the latest expert recommendations.

First Clinical Trial to Study Blood Cancer Patients with COVID-19

The trial will test the drug acalabrutinib in those with acute myeloid leukemia, acute lymphoblastic leukemia and myelodysplastic syndromes.
T cells attack a cancer cell

FDA Approves New CAR-T Therapy for Mantle Cell Lymphoma

Tecartus led to durable remission in a majority of participants in a Phase II study.

Lower Survival for U.S. Hispanics with Blood Cancers Who Live Near Mexico

Hispanic blood cancer patients living at the U.S./Mexico border may have lower overall survival than those who live in other parts of Texas.

Calculating the Risk of Heart Failure for a Common Leukemia Treatment

Researchers designed a calculator to predict who among those receiving treatment for two forms of acute leukemia are at highest risk.
Blinatumomab binds to CD19, a protein on the surface of B-ALL cells, and CD3, a protein on T cells, helping the T cells recognize and kill the cancer cells.

Blincyto Improves Outcomes for Some Children With Relapsed Leukemia

Investigators wanted to see if blinatumomab could increase survival rates free from leukemia and be less toxic than intensive chemotherapy.
Advertisement
Features
Newsfeed

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.